INTRODUCTION
Relapsing polychondritis (RP) is a rare autoimmune disorder of unknown etiology that primarily affects cartilaginous tissues [
1]. RP is characterized by recurrent episodes of inflammation, that causes progressive anatomical deformation and functional impairment of primarily the auricular cartilage, the nasal cartilage, and the respiratory tract [
1,
2]. McAdam et al. [
3] proposed that RP can be diagnosed when three or more of these features are present, along with a positive biopsy from the affected tissue: (1) recurrent chondritis of both auricles; (2) nonerosive inflammatory polyarthritis; (3) chondritis of nasal cartilage; (4) inflammation of ocular structures, including conjunctivitis, keratitis, scleritis, episcleritis, and uveitis; (5) chondritis in the respiratory tract involving laryngeal and/or tracheal cartilages; and (6) cochlear and/or vestibular damage manifesting as sensorineural hearing loss, tinnitus, or vertigo. Damiani and Levine modified this criteria as followed: (1) at least three or more of McAdam’s diagnostic features with or without histologic findings; (2) one or more of McAdam’s diagnostic features with histologic findings of RP; and (3) chondritis in two or more separate locations with response to steroids and/or Dapson [
4]. Nasal chondritis is present in 24% of patients at the time of diagnosis and develops subsequently in 53% throughout the disease’s progress [
5]. Progressive nasal chondritis leads to the flattening of the nasal bridge, resulting in the painless irreversible saddle nose deformity [
1]. However, the number of patients treated for saddle nose deformity remains limited due to the small number of patients reported and the case reports are heterogeneous with different outcomes [
1]. Here, we present a case of a RP patient treated at our department to correct his saddle nose deformity. Our patient underwent costal cartilage grafting and attained good results with neither relapse of nasal chondritis nor donor site problems.
CASE REPORT
A 35-year-old man was diagnosed with RP at another hospital after uncontrolled (showing resistance to antibiotics) pain and swelling in his right ear. During the patient’s initial visit to Konkuk University Medical Center at January 2007 with a chief complaint of hoarseness, the patient was under oral administration of prednisolone (PSL) to 17.5 mg/day and showed severe saddle nose deformity and deformity of the both external ears (
Fig. 1). The patient’s non-enhanced chest computer tomography showed diffuse thickening of the proximal trachea and mild narrowing at expiration (
Fig. 2). The patient was diagnosed with acute labyrinthitis after complaining of otalgia and dizziness. As the patient showed four features of McAdam’s diagnostic criteria for RP, we re-confirmed the diagnosis and increased the oral administration of PSL to 40 mg/day. Also after plasmapheresis, erythrocyte sedimentation rate dropped down to 2 from 68 mm/hr. The patient was referred to our department on August 2010, after cessation of PSL treatment for 3 months. As the patient showed symptoms under control for over 15 months with a PSL maintenance dose of 5 mg/day and no signs of aggravation without PSL for 3 months, we planned surgery to correct his saddle nose deformity with costal cartilage grafting.
An open rhinoplasty technique was used and after dissection, blunting of the anterior septal angle and destruction of the upper lateral cartilage were obvious. A portion of the 8th costal cartilage was harvested and carved with a blade to mimic a silicone implant (
Fig. 3). The carved cartilage fragment was inserted into the subperiosteal pocket of the nasal dorsum. The remaining costal cartilage was used to support the columella as a strut graft (
Fig. 4).
The patient showed good esthetic results with neither complication nor relapse of RP for 6 months after surgery (
Fig. 5). Two episodes of RP recurrence occurred after surgery (15 months and 4 years after the surgery). On the first episode, the patient complained of ocular pain and was diagnosed with episcleritis. On the second episode, the patient complained of diplopia and severe coughing. Both episodes were controlled with oral steroid therapy. Based on the medical records of the rheumatologist, throughout the two episodes of relapse, the patient had no complaints of change of neither nasal position and contour nor chest pain at the donor site.
The requirement for informed consent was waived, and this study was approved by the Institutional Review Board of our center (IRB No. 2019-07-058).
DISCUSSION
The surgical approach to correct the saddle nose deformity caused by RP has no established reasonable argument thus far. Due to its rare feature, only a few patients undergo rhinoplasty. There are also concerns regarding the viability of rhinoplasty in these patients as the surgery itself may accelerate the inflammatory response and break down the plateau status [
6]. Therefore, the decision and timing of the surgery must be considered in the context of disease status and patient condition and is best planned in consultation with rheumatologists [
7]. Surgery seems appropriate after immunological treatment or after the disorder has come to a stable remission [
8].
Our patient underwent surgery when symptoms were stable even after cessation of oral steroid. The patient showed no relapse of RP over 15 months when the first episode of relapse occurred. After PSL treatment, the disorder showed stable remission for almost another 3 years.
In previous cases reporting surgical treatment for saddle nose deformities caused by RP, silicone implants [
9], calvarial bone grafts [
10], iliac bone [
2], and rib cartilage [
8] were used to reconstruct the septum.
Autologous grafts are preferential to alloplastic implants because of their high biocompatibility and low risk of infection and extrusion [
11]. In addition, the possibility that implants may raise a foreign body reaction leading to relapse of RP meant that alloplastic materials such as screws were not used for this case.
We selected the costal cartilage as the grafting material for several reasons. The relapsing characteristic of RP led us to believe that surgical treatment should not be aggressive as it can trigger the inflammation. In this regard, we needed a large-size autologous material that could be easily harvested. We decided that relatively easily obtained rib cartilage could be an option and costal cartilage seemed suitable to meet the demands of large defects. In addition, costal cartilage resembles nasal cartilage more than bone graft and is easier to mold and carve to the optimal shape, and considering the patients age and the final results for which we aimed, costal cartilage was used. Furthermore, as the patient had neither involvement from the costal cartilage nor history of chest pain, we decided at the time of surgery that the costal cartilage was not a contraindication for our case.
However, we do agree that this may not always be the case. In the study of Maciazek-Chyra et al. [
12], one patient out of 10 (20%) showed costal chondritis and Borgia et al. [
1] also reported that involvement of costal cartilages occurs in 35% of patients, but rare at the moment of diagnosis. This means that though our patient showed no signs of costal chondritis at diagnosis or time of surgery, it may occur within lifetime. However, to our knowledge there are no reports of costal chondritis after reconstruction with autologous costal cartilage grafting and uncertainty of the pathophysiology of RP makes it difficult to prevent this. Therefore, we should be cautious of chest wall pain or swelling to engage in an early stage to control the symptoms.
Few patients with RP undergo reconstructive rhinoplasty, which makes it difficult for us to prove that this would work out for all RP patients. However, the fact that the patient retained good esthetic results, showed no complication nor relapse of RP at 6-month follow-up, and still retained acceptable nasal shape and contour without donor site problems even after two relapse episodes of RP throughout the next 4 years, costal cartilage seems an option for reconstruction in RP patients with saddle nose deformity.
In conclusion, deliberate selection of donor graft must be beforehand any surgical procedure and we suggest the use of costal cartilage in reconstructive rhinoplasty for RP patients with saddle nose deformity, particularly among the relatively younger population without involvement of costal cartilage who seek optimal esthetic results.